FDA Inspection
Ipsen BioPharm LtdIpsen BioPharm Ltd – FDA Inspection, Jul 6, 2018
Record Details
This FDA Inspection record concerns Ipsen BioPharm Ltd, with an inspection on July 6, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
- People
- Arie Menachem (Issuing Officer)
- Xiaokuang Lai (FDA Associated Person)
View Company Profile
ID · 69366ac8-adf9-4c93-9106-0b8e9dab48c7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1059005
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of Ipsen BioPharm Ltd
7| Date | Classification | Office | Project area |
|---|---|---|---|
| May 22, 2025 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 26, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 12, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 20, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 8, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Ipsen BioPharm Ltd
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.